Minimally Invasive Cordotomy for Refractory Cancer Pain: A Randomized Controlled Trial.
Ashwin ViswanathanAditya VedantamKenneth R HessJewel OchoaPatrick M DoughertyAkhila S ReddyDhanalakshmi KoyyalaguntaSuresh ReddyEduardo BrueraPublished in: The oncologist (2019)
This prospective clinical trial was designed to determine the improvement in pain intensity in patients randomized to either undergo cordotomy or comprehensive palliative care for medically refractory cancer pain. This study shows that cordotomy is effective in reducing pain for medically refractory cancer pain, and these results can be used to design a large-scale comparative randomized controlled trial that could provide the evidence needed to include cordotomy as a treatment modality in the guidelines for cancer pain management.
Keyphrases
- pain management
- chronic pain
- papillary thyroid
- randomized controlled trial
- neuropathic pain
- palliative care
- clinical trial
- squamous cell
- study protocol
- open label
- childhood cancer
- squamous cell carcinoma
- spinal cord
- chronic kidney disease
- high intensity
- clinical practice
- postoperative pain
- advanced cancer
- smoking cessation